You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Zanolimumab

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell Lymphoma Trial (CHOP + CD4, CHOP)

Terminated
Has Results
  • T-cell Lymphoma
  • (no location specified)
May 2, 2022

Metastatic Melanoma, Metastatic Renal Cancer Trial run by the NCI (Zanolimumab, Aldesleukin)

Terminated
Has Results
  • Metastatic Melanoma
  • Metastatic Renal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 6, 2015

Cutaneous T-Cell Lymphoma Trial in Stanford, Houston (HuMax-CD4)

Completed
  • Cutaneous T-Cell Lymphoma
  • Stanford, California
  • +1 more
Dec 5, 2012

Cutaneous T-Cell Lymphoma Trial in Worldwide (HuMax-CD4)

Completed
  • Cutaneous T-Cell Lymphoma
  • Stanford, California
  • +4 more
Dec 5, 2012

Rheumatoid Arthritis Trial in Canada, United States (HuMax-CD4)

Terminated
  • Rheumatoid Arthritis
  • Montgomery, Alabama
  • +53 more
Dec 5, 2012

Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (HuMax-CD4 (zanolimumab))

Terminated
  • Mycosis Fungoides
  • Sezary Syndrome
  • HuMax-CD4 (zanolimumab)
  • Birmingham, Alabama
  • +34 more
Jul 24, 2012